Dissolution and In-Vitro Release Testing

Dissolution Method Development

Dissolution method development requires careful selection of an appropriate dissolution medium, generally aqueous buffer systems spanning the physiological pH range, chosen to reflect the solubility characteristics of the drug and, where relevant, to achieve sink conditions in which the dissolution medium volume is sufficient to maintain drug concentration well below saturation solubility throughout the test. Apparatus selection, rotation speed, medium volume, and sampling time points are optimised to produce a discriminating dissolution profile capable of distinguishing between batches of differing quality while remaining sufficiently robust to yield reproducible results across laboratories. Surfactants may be incorporated into the dissolution medium to enhance the solubility of poorly water-soluble drugs and thereby maintain sink conditions.

Selection of an appropriately discriminating dissolution method requires a careful balance, since a method that is too discriminating may generate excessive batch-to-batch variability unrelated to true product quality, whereas a method that is insufficiently discriminating may fail to detect meaningful differences in formulation or manufacturing performance.

Dissolution method development is the process of selecting suitable experimental conditions to accurately measure the rate and extent at which a drug is released from its dosage form (tablet or capsule) into a dissolution medium. The method should be reliable, reproducible, and capable of distinguishing differences between formulations.

What is a dissolution medium?

It is the liquid in which the tablet or capsule is placed to simulate the conditions of the gastrointestinal tract.

Why is it important?

Different drugs dissolve differently depending on the pH of the surrounding fluid. Therefore, a suitable medium must be selected.

Common dissolution media

Medium Typical pH Simulates
0.1 N Hydrochloric Acid 1.2 Stomach
Acetate Buffer 4.5 Upper intestine
Phosphate Buffer 6.8 Small intestine
Water ~7.0 Neutral medium
Phosphate Buffer 7.4 Physiological fluid

Goal: Choose a medium that resembles the environment where the drug is expected to dissolve.

What are sink conditions?

Sink conditions mean the drug concentration in the dissolution medium should remain much lower than its saturation solubility (generally less than 10–30%).

Why?

If the solution becomes saturated, the drug will dissolve more slowly, giving inaccurate results.

How are sink conditions maintained?

  • Use an adequate volume of dissolution medium (e.g., 500–1000 mL).
  • Select a medium in which the drug has sufficient solubility.
  • Add a surfactant if necessary.

Goal: Allow the drug to dissolve continuously without saturation.

The USP recommends different apparatus depending on the dosage form.

Apparatus 1 – Basket Method

Suitable for:

  • Capsules
  • Floating dosage forms
  • Soft gelatin capsules

Advantages:

  • Prevents floating of dosage forms.
  • Useful for formulations that tend to rise to the surface.

Apparatus 2 – Paddle Method

Suitable for:

  • Tablets
  • Most immediate-release dosage forms

Advantages:

  • Simple to operate.
  • Most commonly used.
  • Provides good mixing of the dissolution medium.

Goal: Select the apparatus that best suits the dosage form.

Several experimental parameters must be optimized.

Rotation Speed

The paddle or basket rotates at a fixed speed to ensure uniform mixing. Typical speed: 50–150 rpm. Higher speed generally increases the dissolution rate.

Medium Volume

Common volumes include:

  • 500 mL
  • 900 mL
  • 1000 mL

The selected volume should maintain sink conditions.

Sampling Time

Samples are withdrawn at predetermined intervals. Typical sampling times:

  • 5 min
  • 10 min
  • 15 min
  • 30 min
  • 45 min
  • 60 min

These samples are analyzed using UV spectroscopy or HPLC.

Why?

Some drugs are poorly soluble in water. A surfactant improves the wetting and solubility of such drugs.

Common surfactant

Sodium Lauryl Sulfate (SLS) — it helps maintain sink conditions and ensures complete dissolution.

Goal: Improve dissolution without changing the drug's characteristics.

After selecting all conditions, the method is optimized and validated. The method should be:

  • Accurate
  • Precise
  • Robust
  • Reproducible
  • Capable of detecting differences between formulations

The dissolution profile is a graph that compares drug release over time for different batches, with time (minutes) plotted on the x-axis and percentage of drug released plotted on the y-axis.

Interpretation

  • Batch A (Blue): Fastest drug release.
  • Batch B (Green): Moderate drug release.
  • Batch C (Red): Slowest drug release.

The dissolution profile helps compare formulations and ensure consistent product quality.

Basket (USP Apparatus 1) Paddle (USP Apparatus 2)
Suitable for capsules Suitable for tablets
Prevents floating Most widely used
Used for floating dosage forms Simple and economical
Less common for tablets Preferred for most formulations

During method development, the following parameters must be carefully controlled:

  1. pH of the dissolution medium
  2. Type of apparatus (Basket or Paddle)
  3. Rotation speed (RPM)
  4. Volume of dissolution medium
  5. Sampling time points
  6. Temperature (usually 37 ± 0.5°C)

Even small changes in these parameters can significantly affect the dissolution results.

1. Discriminating Method

A good dissolution method should detect differences between good and poor-quality formulations.

2. Balance

The method should not be too sensitive (causing unnecessary variability), or too insensitive (failing to detect formulation differences).

3. Robust and Reproducible

The method should produce consistent results between different analysts, on different instruments, on different days, and in different laboratories.

4. Evaluate Method Performance

The method should be assessed for accuracy, precision, robustness, and reproducibility.

A well-developed dissolution method accurately measures how a drug is released from a dosage form under simulated physiological conditions. It requires selecting an appropriate dissolution medium, maintaining sink conditions, choosing the correct apparatus, optimizing operating parameters, and validating the method. A robust dissolution method supports formulation development, quality control, regulatory compliance, and helps predict the in vivo performance of pharmaceutical products.